KYMERA THERAPEUTICS, INC. Finance Lease, Principal Payments
KYMERA THERAPEUTICS, INC. (KYMR) reported Finance Lease, Principal Payments of $122.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2026-06-30 was $56.00K, a 27.27% decline year-over-year.
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2026-03-31 was $66.00K, a 14.29% decline year-over-year.
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2025-12-31 was $75.00K, a 8.70% increase year-over-year.
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2025-09-30 was $83.00K, a 76.60% increase year-over-year.
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for fiscal 2025 was $312.00K, a 51.46% increase from fiscal 2024.
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for fiscal 2024 was $206.00K, a 13.81% increase from fiscal 2023.
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for fiscal 2023 was $181.00K, a 1.12% increase from fiscal 2022.
- KYMERA THERAPEUTICS, INC. finance lease, principal payments for fiscal 2022 was $179.00K, a 13.29% increase from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $122.00K 10-Q · filed 2026-08-05 | $197.00K derived: sum of 3 quarters · filed 2026-08-05 | $280.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $66.00K 10-Q · filed 2026-04-30 | $141.00K derived: sum of 2 quarters · filed 2026-04-30 | $224.00K derived: sum of 3 quarters · filed 2026-04-30 | $301.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $158.00K derived: sum of 2 quarters · filed 2026-02-26 | $235.00K derived: sum of 3 quarters · filed 2026-08-05 | $312.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $160.00K derived: sum of 2 quarters · filed 2026-08-05 | $237.00K 10-Q · filed 2025-11-04 | $306.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $154.00K 10-Q · filed 2026-08-05 | $223.00K derived: sum of 3 quarters · filed 2026-08-05 | $270.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $77.00K 10-Q · filed 2026-04-30 | $146.00K derived: sum of 2 quarters · filed 2026-04-30 | $193.00K derived: sum of 3 quarters · filed 2026-04-30 | $234.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $116.00K derived: sum of 2 quarters · filed 2026-02-26 | $157.00K derived: sum of 3 quarters · filed 2026-02-26 | $206.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $88.00K derived: sum of 2 quarters · filed 2025-11-04 | $137.00K 10-Q · filed 2025-11-04 | $185.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $90.00K 10-Q · filed 2025-08-11 | $138.00K derived: sum of 3 quarters · filed 2025-08-11 | $175.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $49.00K 10-Q · filed 2025-05-09 | $97.00K derived: sum of 2 quarters · filed 2025-05-09 | $134.00K derived: sum of 3 quarters · filed 2025-05-09 | $178.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $85.00K derived: sum of 2 quarters · filed 2025-02-27 | $129.00K derived: sum of 3 quarters · filed 2025-02-27 | $181.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $81.00K derived: sum of 2 quarters · filed 2024-10-31 | $133.00K 10-Q · filed 2024-10-31 | $188.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $96.00K 10-Q · filed 2024-08-07 | $151.00K derived: sum of 3 quarters · filed 2024-08-07 | $189.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $52.00K 10-Q · filed 2024-05-02 | $107.00K derived: sum of 2 quarters · filed 2024-05-02 | $145.00K derived: sum of 3 quarters · filed 2024-05-02 | $185.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $93.00K derived: sum of 2 quarters · filed 2024-02-22 | $133.00K derived: sum of 3 quarters · filed 2024-02-22 | $179.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $78.00K derived: sum of 2 quarters · filed 2023-11-02 | $124.00K 10-Q · filed 2023-11-02 | $176.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $86.00K 10-Q · filed 2023-08-03 | $138.00K derived: sum of 3 quarters · filed 2023-08-03 | $207.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $46.00K 10-Q · filed 2023-05-04 | $98.00K derived: sum of 2 quarters · filed 2023-05-04 | $167.00K derived: sum of 3 quarters · filed 2023-05-04 | $180.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $121.00K derived: sum of 2 quarters · filed 2023-02-23 | $134.00K derived: sum of 3 quarters · filed 2023-02-23 | $158.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $82.00K derived: sum of 2 quarters · filed 2022-11-03 | $106.00K 10-Q · filed 2022-11-03 | $133.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $37.00K 10-Q · filed 2022-08-09 | $64.00K derived: sum of 3 quarters · filed 2022-08-09 | $93.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $24.00K 10-Q · filed 2022-05-03 | $51.00K derived: sum of 2 quarters · filed 2022-05-03 | $80.00K derived: sum of 3 quarters · filed 2022-05-03 | $111.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $56.00K derived: sum of 2 quarters · filed 2022-02-24 | $87.00K derived: sum of 3 quarters · filed 2022-02-24 | $121.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $60.00K derived: sum of 2 quarters · filed 2021-11-10 | $94.00K 10-Q · filed 2021-11-10 | $463.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $65.00K 10-Q · filed 2021-08-06 | $434.00K derived: sum of 3 quarters · filed 2021-08-06 | |
| 2020-03-31 | $34.00K 10-Q · filed 2021-05-06 | $403.00K derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $385.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $16.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |